About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Baltimore | 13,685 Studies Near You

Clinical TrialsBaltimore

Clinical Trials in Baltimore

Discover 13,685 clinical trials near Baltimore, Maryland. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1161-1180 of 13,685 trials

CompletedOpen-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.This was an open-label study to evaluate the long-term efficacy and safety of KZR-616 in patients with active polymyositis (PM) or dermatomyositis (DM) who completed the…NCT04628936·Beverly Hills, California and 9 others RecruitingImproving Outcomes for Patients With Life-Threatening Neurologic IllnessBackground: While the intensive care of patients with life-threatening brain illnesses has advanced tremendously, a large number of therapies are still without proper scientific…NCT04189471·Baltimore, Maryland

Find Trials by Condition in Baltimore

Breast Cancerin Baltimore Lung Cancerin Baltimore Prostate Cancerin Baltimore Colorectal Cancerin Baltimore Melanomain Baltimore Leukemiain Baltimore Lymphomain Baltimore Pancreatic Cancerin Baltimore Ovarian Cancerin Baltimore Brain Cancerin Baltimore

Data from ClinicalTrials.govTerms

CompletedEfficacy of Rifaximin in Preventing CampylobacteriosisThis study is a randomized, double-blinded, placebo-controlled, in-patient trial evaluating the prophylactic efficacy of rifaximin against campylobacteriosis following challenge…NCT02280044·Baltimore, Maryland

Active not recruitingCommunity Engagement Alliance Against DisparitiesThe Community Engagement Alliance against Disparities - Washington District of Columbia, Maryland, Virginia (CEAL DMV), is a multi-community and multi-university consortium.NCT06607341·Washington D.C., District of Columbia and 1 other

CompletedACE527 Safety and Immunogenicity StudyThe purpose of this study is to evaluate the safety and immune response to ACE527.NCT00901654·Baltimore, Maryland

CompletedA Phase 1/2a to Evaluate the Safety and Efficacy of Adipose Tissue Allograft (BRC-OA) in Patients With Osteoarthritis of the KneeThe purpose of this study is to evaluate the safety profile of BRC-OA for pain treatment in patients with mild to severe OA of the knee, focusing particularly on two distinct…NCT06828666·Baltimore, Maryland and 6 others

CompletedCombination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney TumorsThis phase II trial is studying how well combination chemotherapy, radiation therapy, and/or surgery work in treating patients with high-risk kidney tumors.NCT00335556·Birmingham, Alabama and 186 others

CompletedPREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1The purpose of this clinical research study was to determine the safety and effectiveness of an experimental drug called rilonacept in subjects with gout who are beginning…NCT00829829·Birmingham, Alabama and 90 others

CompletedA Relative Bioavailability Study of Staccato Alprazolam Versus Oral Alprazolam in Healthy Study ParticipantsThe purpose of the study is to evaluate the relative bioavailability of alprazolam in plasma following a single dose of Staccato alprazolam compared to a single dose of oral…NCT05626439·Baltimore, Maryland

RecruitingA Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First EventThe purpose of this phase 3, randomized, placebo controlled, event-driven study is to assess the effect of AZD0780, an oral PCSK9 inhibitor, compared with placebo in reducing the…NCT07000357·Athens, Alabama and 1451 others

CompletedACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients With Severe SepsisThe purpose of this study is to compare eritoran tetrasodium and placebo in patients with severe sepsis and to demonstrate a reduction of mortality from all causes.NCT00334828·Birmingham, Alabama and 250 others

CompletedUCN-01 and Carboplatin in Treating Patients With Advanced Solid TumorsPhase I trial to study the effectiveness of combining UCN-01 with carboplatin in treating patients who have advanced solid tumors.NCT00036777·Baltimore, Maryland

CompletedAfrican American Study of Kidney Disease and Hypertension ABPM Pilot Study4\. Methods 4a.NCT00582777·Birmingham, Alabama and 15 others

CompletedEffect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)The primary objective is to determine the efficacy of AMR101 (ethyl icosapentate) compared to placebo in lowering high fasting triglyceride levels in patients with high risk for…NCT01047501·Muscle Shoals, Alabama and 79 others

CompletedEfficacy of Bevacizumab (Avastin) in Treatment of Acute NMO ExacerbationsThis is a phase 1b interventional trial of bevacizumab (Avastin®) to evaluate the tolerability/safety and preliminary efficacy of bevacizumab (Avastin®) as add-on therapy for…NCT01777412·Baltimore, Maryland

RecruitingA Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseaseThe goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 40-80 years with early Parkinson's Disease (PD) who have…NCT06680830·Sun City, Arizona and 71 others

CompletedA Study of the Concurrent Use of AGN-190584 and AGN-199201 in Participants With PresbyopiaThis study will identify the optimum concentrations of AGN-199201 and AGN-190584 when dosed in combination once a day for the improvement of uncorrected near visual acuity in…NCT02595528·Artesia, California and 19 others

CompletedPhase III Study in Refractory Behcet's DiseaseThe purpose of this pivotal trial is to evaluate subcutaneous (SQ) AIN457 as an adjunctive therapy to reduce the rate of exacerbations of posterior uveitis or panuveitis secondary…NCT00995709·Baltimore, Maryland and 48 others

CompletedA Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-SulfadiazineTo evaluate the safety and tolerance of atovaquone (566C80) in AIDS patients with central nervous system (CNS) toxoplasmosis.NCT00001994·Los Angeles, California and 21 others

CompletedUsing Mobile Health to Respond Early to Acute Exacerbations of COPD in HIVInvestigators propose to develop methods to improve early identification of acute exacerbations of COPD (AECOPD) among HIV-infected individuals.NCT01892566·Baltimore, Maryland

PreviousPage 59 of 685Next

Diabetes

in Baltimore

Heart Diseasein Baltimore